[
    [
        {
            "time": "",
            "original_text": "融资客最看好个股一览",
            "features": {
                "keywords": [
                    "融资客",
                    "看好",
                    "个股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "融资客最看好个股一览",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-08",
            "original_text": "【医药徐佳熹】板块性价比提升，布局细分龙头||医药行业2018年8月份投资月报",
            "features": {
                "keywords": [
                    "医药",
                    "板块",
                    "性价比",
                    "细分龙头",
                    "投资月报"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药徐佳熹】板块性价比提升，布局细分龙头||医药行业2018年8月份投资月报",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "七月衰基金之四：浦银安盛医疗健康跌超6% 三年亏两成",
            "features": {
                "keywords": [
                    "七月",
                    "基金",
                    "浦银安盛",
                    "医疗健康",
                    "下跌",
                    "亏损"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "七月衰基金之四：浦银安盛医疗健康跌超6% 三年亏两成",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]